B2B Investment Surge: Qure.ai Seeks $60 Million Funding for AI-Powered Radiology Solutions
B2B Opportunities in Medtech
With rapid digitalisation and automation pushing the growth of the medtech industry, Qure.ai, a Mumbai-based startup, is reportedly seeking to raise around $50-60 Mn in a funding exercise to be led by Lightspeed.
Investment Details
As per ET's report, the infusion will likely include a secondary deal, alongside existing investors contributing primary capital. This investment round is expected to conclude by the end of this month.
- Lightspeed is investing about $20-25 Mn, with plans to acquire some secondary shares.
- The total funding might reach $50-60 Mn, depending on the definitive secondary component.
About Qure.ai
Founded in 2016 by Pooja Rao and Prashant Warier, Qure.ai leverages artificial intelligence for medical imaging diagnostics, effectively detecting brain trauma and chest diseases. Their algorithms provide rapid identification of clinically relevant trauma from X-rays, CT Scans, and MRIs.
Growing Interest in AI in Pharma
This funding interest aligns with the growing adoption of AI technologies within the pharmaceutical sector. Healthtech companies are witnessing increased investments, highlighted by Innovaccer's discussions with Kaiser Permanente to raise a substantial $200-250 Mn.
Previously, Qure.ai raised $40 Mn in a strategic funding round led by Novo Holdings and HealthQuad to bolster its global outreach across the US and Europe.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.